Katoh N, Tanaka A, Takahashi H, Shimizu R, et al. Long-term management of moderate-to-severe atopic dermatitis with lebrikizumab and concomitant topical corticosteroids: a 68-week, randomized, double-blind, placebo-controlled phase III trial in Japan (ADhere-J). Br J Dermatol 2024 Oct 23:ljae394. doi: 10.1093.
PMID: 39442013